4559:TYO
Zeria Pharmaceutical Co Ltd
1 909,00 JP¥
arrow_upward
+0,32%(+6,00) 1D
6 tet, 1:09:01 m.d., GMT+9 · JPY
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 4559...
Hap
1 903 JP¥
I lartë
1 919 JP¥
I ulët
1 900 JP¥
Kapitalizimi i tregut
95,68 mld
Vëllimi mesatar
169,91 mijë
Vëllimi
67,60 mijë
Dividendi
2,57%
Dividendi tremujor
12 JP¥
Data e ndërprerjes së dividendit
29 sht 2026
Raporti çmim/fitim
10,22
Maksimumi 52-javor
2 434 JP¥
Minimumi 52-javor
1 878 JP¥
Fitimet për aksion
187 JP¥
Aksionet në qarkullim
50,11 mln
Numri i punonjësve
2 mijë
Hap
1 903 JP¥
I lartë
1 919 JP¥
I ulët
1 900 JP¥
Kapitalizimi i tregut
95,68 mld
Vëllimi mesatar
169,91 mijë
Vëllimi
67,60 mijë
Dividendi
2,57%
Dividendi tremujor
12 JP¥
Data e ndërprerjes së dividendit
29 sht 2026
Raporti çmim/fitim
10,22
Maksimumi 52-javor
2 434 JP¥
Minimumi 52-javor
1 878 JP¥
Fitimet për aksion
187 JP¥
Aksionet në qarkullim
50,11 mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
GreenevilleSun.com
·
54 minuta më parë
US stocks rise to the edge of an all-time high
Yahoo Finance
·
1 orë më parë
The Bond Market Just Sent Investors a Warning. Here's the Mistake I'd Avoid Making With the S&P 500.
AFP.com
·
1 orë më parë
Asian stocks mixed despite tech-led Wall St record
Profili
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Rreth Zeria Pharmaceutical Co Ltd
Drejtori ekzekutivSachiaki Ibe
Punonjësit1,75 mijë
Themeluar më22 dhj 1955
Selia-
Sektori-
Uebsajtizeria.co.jp